Valuation: BioGaia AB

Market Cap 11.13B 1.13B 984M 929M 844M 1.58B 108B 1.59B 4.29B 55.04B 4.24B 4.14B 177B P/E 2026 *
28.8x
P/E 2027 * 23.5x
Enterprise Value 10.46B 1.06B 925M 873M 793M 1.49B 102B 1.49B 4.04B 51.74B 3.98B 3.9B 166B EV / Sales 2026 *
6.27x
EV / Sales 2027 * 5.59x
Free-Float
80.82%
Yield 2026 *
2.68%
Yield 2027 * 2.91%
1 day+1.76%
1 week+2.23%
Current month-4.10%
1 month-4.84%
3 months-6.94%
6 months-4.35%
Current year+3.58%
1 week 105.4
Extreme 105.4
111.1
1 month 105.4
Extreme 105.4
117.8
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 92.95
Extreme 92.95
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 48.7
Extreme 48.7
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
13/02/26 Buy

Director

582 0.0006%
30/12/25 Buy

General Counsel

390 0.0004%
05/12/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
+1.76%+2.23%+4.17%+17.58% 1.11B
-0.58%+0.43%+31.09%-4.81% 78.83B
-2.55%+6.99%+505.27%+47.92% 63.11B
-1.11%+5.08%-11.47%-33.91% 60.48B
+0.14%-1.20%-11.64%+24.21% 46.75B
-0.24%+1.22%+2.26%+151.03% 45.66B
-1.62%-0.76%+49.85%-14.92% 32.37B
-1.81%+3.16%+45.71%+110.57% 25.87B
+0.47%+3.26%-0.77%+142.41% 21.33B
+0.27%+1.96%+62.19%+102.81% 15.8B
Average -0.53%+1.74%+67.67%+54.29% 39.13B
Weighted average by Cap. -0.92%+2.22%+94.48%+40.08%

Financials

2026 *2027 *
Net sales 1.67B 169M 148M 139M 127M 237M 16.24B 238M 644M 8.26B 636M 622M 26.57B 1.88B 190M 166M 157M 142M 267M 18.26B 268M 724M 9.28B 715M 699M 29.87B
Net income 387M 39.24M 34.22M 32.31M 29.34M 54.97M 3.77B 55.2M 149M 1.91B 147M 144M 6.16B 474M 48.06M 41.91M 39.57M 35.93M 67.32M 4.61B 67.61M 183M 2.34B 181M 177M 7.54B
Net Debt -667M -67.63M -58.97M -55.68M -50.56M -94.74M -6.49B -95.13M -257M -3.3B -254M -248M -10.62B -646M -65.45M -57.07M -53.89M -48.93M -91.68M -6.28B -92.07M -249M -3.19B -246M -240M -10.27B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
18/09/26 SEK 110.00 +1.76% 254,052
17/09/26 SEK 108.10 +0.84% 381,040
16/09/26 SEK 107.20 -0.09% 326,526
15/09/26 SEK 107.30 0.00% 201,025
14/09/26 SEK 107.30 -0.28% 80,643
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
110.00SEK
Average target price
152.50SEK
Spread / Average Target
+38.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!